Katelyn Melgar
Instructor of Clinical Fellow, Internal Medicine · University of Cincinnati College of Medicine
Credentials: · · · ·
History
Research
Overcoming adaptive therapy resistance in AML by targeting immune response pathways
Science Translational Medicine · 2019 · First of 25 authors · 80 citations
Targeting AML-associated FLT3 mutations with a type I kinase inhibitor
Journal of Clinical Investigation · 2020 · 38 citations
Deconstructing innate immune signaling in myelodysplastic syndromes
Review · Experimental Hematology · 2015 · 35 citations
2 papers
2 papers · 1 as a fellow
- EB
1 paper
1 paper
Grants
- 2017–2020
Novel Mechanisms and Therapeutic Strategies of Refractory Leukemia
National Cancer Institute · F31
Contact PI · $111.6K · University of Cincinnati